SCHEMBL8781065

SCHEMBL8781065

NCCNC(=O)c1ccc(-n2ccnc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4Z1 Q86W10 1/20 0.57
CYP3A4 P08684 1/20 0.56
BAZ2B Q9UIF8 1/20 0.56
HTT P42858 1/20 0.56
ADH5 P11766 1/20 0.54
DRD3 P35462 5/20 0.53
ADRB1 P08588 3/20 0.53
ADRB2 P07550 2/20 0.53
ADRB3 P13945 2/20 0.53
CYP1A2 P05177 1/20 0.51
TSHR P16473 1/20 0.51
NFKB1 P19838 1/20 0.51
MAOB P27338 1/20 0.51
HTR2A P28223 1/20 0.51
HTR2C P28335 1/20 0.51
HTR2B P41595 1/20 0.51
MAPT P10636 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
DRD2 P14416 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8781047 0.99 CYP4Z1 (0.56) CYP4Z1CYP3A4BAZ2BHTTADH5
SCHEMBL4674989 0.86 CYP3A4 (0.60) CYP4Z1CYP3A4BAZ2BHTTADH5
SCHEMBL10960777 0.84 CYP3A4 (0.64) CYP4Z1CYP3A4BAZ2BHTTADH5
SCHEMBL9368933 0.83 CYP3A4 (0.63) CYP4Z1CYP3A4BAZ2BHTTADH5
SCHEMBL8508590 0.82 CYP4Z1 (0.65) CYP4Z1ADH5DRD3ADRB1ADRB2
SCHEMBL9363661 0.82 ALDH1A1 (0.58) CYP4Z1CYP3A4BAZ2BHTTDRD3
SCHEMBL7068530 0.82 NAAA (0.63) CYP4Z1CYP3A4BAZ2BHTTDRD3
Hydrochloric Acid SCHEMBL9363955 0.81 BLM (0.59) CYP4Z1CYP3A4BAZ2BHTTDRD3
SCHEMBL5947724 0.80 EPHX2 (0.64) CYP4Z1ADH5DRD3ADRB1ADRB2
SCHEMBL9363630 0.80 DRD3 (0.55) CYP4Z1CYP3A4BAZ2BHTTDRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0358284-B1 Derivatized alkanolamines as cardiovascular agents SCHERING AG (DE) 1997-08-20 EP disclosed
US-5051423-A Derivatized alkanolamines as cardiovascular agents SCHERING AG (DE) 1991-09-24 US disclosed
EP-0358284-A2 Derivatized alkanolamines as cardiovascular agents SCHERING AKTIENGESELLSCHAFT (DE) 1990-03-14 EP disclosed
WO-1990000548-A2 DERIVATIZED ALKANOLAMINES AS CARDIOVASCULAR AGENTS SCHERING AKTIENGESELLSCHAFT BERLIN AND BERGKAMEN (DE) 1990-01-25 WO disclosed